Summary of experimental hut trial results for <i>Anopheles gambiae</i> and the other <i>culicidae</i>.

<p>For each species, the numbers in the same column sharing the letter superscript do not differ significantly (p>0.05). CTN = conventionally treated net.</p

Summary of release-recapture experiments with susceptible and resistant populations of <i>Anopheles gambiae.</i>

<p>For each <i>Anopheles gambiae</i> population, values in columns not sharing the same superscript letter are significantly different at the 5% level.</p

Active ingredient and synergist contents of Olyset® Net and Olyset® Plus net samples used in Phase II trial.

<p></p

Mortality and knock-down (KD) effect at 60 min induced by Olyset® Plus and Olyset Net® unwashed and washed 3 times and after several days of storage.

<p>Mortality and knock-down (KD) effect at 60 min induced by Olyset® Plus and Olyset Net® unwashed and washed 3 times and after several days of storage.</p

Average values of median knock-down time (MKDT) in seconds (±CI₉₅) for samples unwashed and washed 3 times and after several days of storage.

<p>Average values of median knock-down time (MKDT) in seconds (±CI₉₅) for samples unwashed and washed 3 times and after several days of storage.</p

Average values of knock-down (KD) effect after 60 min and mortality at 24 h (±CI₉₅) and active ingredient contents (g/Kg±SE) of Olyset® Plus sample after washes.

<p>Average values of knock-down (KD) effect after 60 min and mortality at 24 h (±CI₉₅) and active ingredient contents (g/Kg±SE) of Olyset® Plus sample after washes.</p

Differentially expressed salivary gland proteins between the susceptible Kis and resistant AceRKis strains.

<p>Protein identification was performed using MALDI-TOF MS or nanoLC ESI MS/MS (underlined spot#) analysis. Insecta entries of Swiss-Prot and TrEMBL databases were searched by using the MASCOT algorithm, or the Proteome Discoverer software for nanoLC ESI MS/MS spectra. All spots displayed a power >0.9. Spot# refers to the SameSpots analysis spot number (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0103816#pone-0103816-g001" target="_blank">Figure 1A</a>); ^SP indicates the presence of a signal peptide for secretion as predicted by SignalP 4.0 (<i>^SP°</i>: SP in the N-terminal homolog Q5TV62_ANOGA); Fold: fold difference in expression levels between the two strains; Accession: accession number in UniProtKB/Swiss-Prot or UniProtKB/TrEMBL databases (_ANOGA); pI: isoelectric point; Cover: indicates the amino acid coverage (%); *Mascot Score is provided for MALDI-TOF protein identification; for nanoLC ESI MS/MS based identification the peptide sequences and the number of peptides are provided as supporting information (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0103816#pone.0103816.s001" target="_blank">Table S1</a>). Translation IF: Translation Initiation Factor.</p

Differential expression of the salivary proteins between the susceptible Kis and resistant AceRKis SGE extracts.

<p>Differences in protein expression are represented as a function of both expression ratio (resistant/susceptible) and significance ratio (q-value). Vertical dotted lines indicate the 1.5-fold difference in expression level in either direction (x1.5 for a higher expression in the resistant strain and/1.5 for a lower expression in the resistant strain). The horizontal dotted line indicates a q-value  = 0.05 (or 1/q  = 20). Saglin and TRIO proteins display expression level differences above 3 and highly significant q-values.</p

Amino-acid sequence of gSG6 Peptides.

<p>Amino-acid sequence of the SG6 protein of <i>Anopheles gambiae</i> (gi:13537666) is presented and sequences of the selected peptides, gSG6-P1 to gSG6-P5, are underlined. Signal peptide (SP) sequence is indicating by dotted underline.</p

Additional file 8: Table S4. of Efficacy of ULV and thermal aerosols of deltamethrin for control of Aedes albopictus in Nice, France

Results of the GLMM with negative binomial distribution analysis of the influence of the treatment on parity rate. The dependent variable is parity rate and the independent variable pre-post treatment. (DOCX 15 kb